Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Primary antibodies are detailed in Supplementary Table S2
In preclinical and in-vitro studies, FOXO4-DRI has been investigated for its role in senolysis, the selective elimination of senescent ("zombie") cells
Your liver synthesizes it continuously, and every cell in your body relies on it to neutralize free radicals and reduce oxidative damage to cellular structures
Once this interaction is disrupted: p53 is released from the nucleus Cellular self-destruction pathways are activated Senescent cells undergo apoptosis This selective mechanism has made FOXO4-DRI one of the most studied senolytic peptides in modern aging research
Reduces cell damage in fatty liver disease Cell death in the liver may be exacerbated by a deficiency in antioxidants, including glutathione
US$ 28.46
US$ 29.38
US$ 22.21
US$ 29.52
US$ 24.99
US$ 21.79
US$ 23.25
US$ 25.35
US$ 21.63
US$ 20.36
